ES403910A1 - Procedimiento para la preparacion de imidazo (4,5-b) piri- dina. - Google Patents

Procedimiento para la preparacion de imidazo (4,5-b) piri- dina.

Info

Publication number
ES403910A1
ES403910A1 ES403910A ES403910A ES403910A1 ES 403910 A1 ES403910 A1 ES 403910A1 ES 403910 A ES403910 A ES 403910A ES 403910 A ES403910 A ES 403910A ES 403910 A1 ES403910 A1 ES 403910A1
Authority
ES
Spain
Prior art keywords
imidazo
carbon atoms
hydrogen atom
pyridine derivatives
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES403910A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc SA
Original Assignee
Rhone Poulenc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7034133A external-priority patent/FR2105060A1/fr
Priority claimed from FR7130825A external-priority patent/FR2150236A2/fr
Application filed by Rhone Poulenc SA filed Critical Rhone Poulenc SA
Publication of ES403910A1 publication Critical patent/ES403910A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES403910A 1970-09-21 1972-06-15 Procedimiento para la preparacion de imidazo (4,5-b) piri- dina. Expired ES403910A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7034133A FR2105060A1 (en) 1970-09-21 1970-09-21 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use
FR7130825A FR2150236A2 (en) 1971-08-25 1971-08-25 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use

Publications (1)

Publication Number Publication Date
ES403910A1 true ES403910A1 (es) 1975-05-01

Family

ID=26215952

Family Applications (2)

Application Number Title Priority Date Filing Date
ES395260A Expired ES395260A1 (es) 1970-09-21 1971-09-21 Procedimiento para preparacion de imidazo (4,5-b) piridina.
ES403910A Expired ES403910A1 (es) 1970-09-21 1972-06-15 Procedimiento para la preparacion de imidazo (4,5-b) piri- dina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES395260A Expired ES395260A1 (es) 1970-09-21 1971-09-21 Procedimiento para preparacion de imidazo (4,5-b) piridina.

Country Status (13)

Country Link
AU (1) AU453067B2 (es)
BE (1) BE772835A (es)
CA (1) CA940131A (es)
CH (1) CH532600A (es)
DE (1) DE2147103C3 (es)
DK (1) DK131345B (es)
ES (2) ES395260A1 (es)
GB (1) GB1318859A (es)
HU (1) HU163150B (es)
IL (1) IL37752A (es)
LU (1) LU63927A1 (es)
NL (1) NL145553B (es)
SE (1) SE368828B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE298569T1 (de) 1999-03-31 2005-07-15 Uaf Technologies And Res Llc Virus behandlung
US6593466B1 (en) 1999-07-07 2003-07-15 Isis Pharmaceuticals, Inc. Guanidinium functionalized nucleotides and precursors thereof
US6384049B1 (en) 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment

Also Published As

Publication number Publication date
BE772835A (fr) 1972-03-20
AU453067B2 (en) 1974-09-19
LU63927A1 (es) 1972-06-27
CH532600A (fr) 1973-01-15
SE368828B (es) 1974-07-22
IL37752A0 (en) 1971-11-29
DE2147103A1 (de) 1972-03-23
IL37752A (en) 1974-10-22
DK131345C (es) 1975-11-24
DK131345B (da) 1975-06-30
HU163150B (es) 1973-06-28
AU3373571A (en) 1973-03-29
NL145553B (nl) 1975-04-15
CA940131A (en) 1974-01-15
DE2147103C3 (de) 1975-07-17
NL7112971A (es) 1972-03-23
GB1318859A (en) 1973-05-31
ES395260A1 (es) 1973-12-01
DE2147103B2 (de) 1974-11-14

Similar Documents

Publication Publication Date Title
ES413188A1 (es) Procedimiento para preparar un derivado de 2-alquil-3-acil-pirazol (1,5-a) piridina.
ES394370A1 (es) Procedimiento para la preparacion de derivados de la inso-indolina.
ES421068A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas.
ES403910A1 (es) Procedimiento para la preparacion de imidazo (4,5-b) piri- dina.
ES393934A2 (es) Procedimiento para la preparacion de derivados de teofili- na.
ES317454A1 (es) Procedimiento para la preparacion de amidas de derivados de acido lisergico.
ES451466A1 (es) Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina.
ES419739A1 (es) Procedimiento para la preparacion de 2-arilamino-imidazoli-nas (2) sustituidas.
ES438704A1 (es) Procedimiento para preparar derivados de ergopectina.
ES440438A1 (es) Procedimiento para la preparacion de nuevos derivados de fe-nilbutazona.
ES380390A1 (es) Procedimiento para la preparacion de un compuesto de 5-ni- tro-furil-pirazol.
ES382564A1 (es) Procedimiento para la preparacion de derivados de la dihi- dro-10,11 dibenzo (b,f) azepina.
ES385774A1 (es) Procedimiento para la preparacion de nuevas 2-(5-nitro-2- furil)-tieno (3,2-d) pirimidinas.
ES391493A1 (es) Procedimiento para la obtencion de alcaloides del cornezue-lo.
ES429691A1 (es) Proceso para la preparacion del acido p. isobutil-hidratro-pico.
ES441029A1 (es) Procedimiento de preparacion de un nuevo derivado del acido acetilsalicilico.
ES401342A1 (es) Procedimiento para la preparacion de nuevos derivados de lapiridina y de sus sales.
ES387410A1 (es) Un procedimiento de preparacion de nuevas sales de mono- esteres de piridoxina.
ES320083A1 (es) Procedimiento de preparacion de los derivados de la difenilamina.
ES413044A1 (es) Procedimiento de preparacion de fenotiazinas.
ES383342A1 (es) Procedimiento para la preparacion de nuevos derivados de labencensulfonamida.
GB1005023A (en) Preparation of naphthalene derivatives
ES360858A1 (es) Procedimiento para la preparacion de nuevos derivados de tiazepina.
ES393259A1 (es) Un procedimiento para la preparacion de derivados esterifi-cados de piridilbenzopiranos.
ES389536A1 (es) Procedimiento para la preparacion de derivados del benzofu-rano.